Disease State: Diabetes

Educational Objectives

1. Outline the morbidity, mortality and cost burdens that result from inadequate management of T2DM and its complications, and highlight the challenges of caring for the elderly and racially and ethnically diverse populations.
2. Describe the role of aggressive, multifaceted approaches to attaining treatment goals including glycemic control, controlling weight, and reducing macrovascular and microvascular complications.
3. Enhance awareness of the prevalence of renal impairment in T2DM and discuss the importance of early and accurate diagnosis, stage identification, treatment considerations, and follow up.
4. Describe the mechanisms of action and clinical data describing the safety and efficacy of available and emerging therapies in T2DM patients with microvascular and macrovascular complications.
5. Discuss strategies to align and incorporate practice guidelines and consensus recommendations for therapy intensification into patient care to optimize outcomes of T2DM therapies.
6. Discuss appropriate management options for side effects associated with T2DM therapies that often limit patient tolerability.
7. Discuss new models of care in the management of T2DM, including team approaches, group visits, and cooperative healthcare clinics, which may assist providers in delivering improved patient care and educate patients on the importance of self-management of their disease.

 

© 2009-2010 Boehringer Ingelheim Corporation or an affiliated company. All rights reserved. Use of this site is subject to the terms and conditions set out in the Agreement to use the Boehringer Ingelheim Corporation and its U.S. affiliates' web sites. All content intended for U.S. residents only. Terms of Use and Privacy Policy.